Gene · 9563
Papers3,177
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,177
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Electrochemical Oscillatory Baffled Reactors Fabricated with Additive Manufacturing for Efficient Continuous-Flow Oxidations. | ACS Sustain Chem Eng | 2022 | 35223215 | PubTator, text mining | PubMed |
| In Vitro Analysis of Matched Isolates from Localized and Disseminated Gonococcal Infections Suggests That Opa Expression Impacts Clinical Outcome. | Pathogens | 2022 | 35215160 | PubTator, text mining | PubMed |
| Biosensors to Monitor Cell Activity in 3D Hydrogel-Based Tissue Models. | Sensors (Basel) | 2022 | 35214418 | PubTator, text mining | PubMed |
| Glucose/Ribitol Dehydrogenase and 16.9 kDa Class I Heat Shock Protein 1 as Novel Wheat Allergens in Baker's Respiratory Allergy. | Molecules | 2022 | 35209002 | PubTator, text mining | PubMed |
| Electrochemical Sensing of Glucose Using Glucose Oxidase/PEDOT:4-Sulfocalix [4]arene/MXene Composite Modified Electrode. | Micromachines (Basel) | 2022 | 35208428 | PubTator, text mining | PubMed |
| COVID-19 Infection in Children and Infants: Current Status on Therapies and Vaccines. | Children (Basel) | 2022 | 35204969 | PubTator, text mining | PubMed |
| Whole-cell biocatalysis using genetically modified Pseudomonas taetrolens for efficient production of maltobionic acid from pure maltose and high-maltose corn syrup. | Bioprocess Biosyst Eng | 2022 | 35201399 | PubTator, text mining | PubMed |
| Functional Genetic Diversity and Plant Growth Promoting Potential of Polyphosphate Accumulating Bacteria in Soil. | Microbiol Spectr | 2022 | 35196785 | PubTator, text mining | PubMed |
| Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. | Molecules | 2022 | 35163973 | PubTator, text mining | PubMed |
| Fabrication of Fragment Antibody-Enzyme Complex as a Sensing Element for Immunosensing. | Int J Mol Sci | 2022 | 35163258 | PubTator, text mining | PubMed |
| The role of the microRNA regulatory network in Alzheimer's disease: a bioinformatics analysis. | Arch Med Sci | 2022 | 35154541 | PubTator, text mining | PubMed |
| One pot purification and co-immobilization of His-tagged old yellow enzyme and glucose dehydrogenase for asymmetric hydrogenation. | Enzyme Microb Technol | 2022 | 35151127 | PubTator, text mining | PubMed |
| Discovery of Potent Glucokinase and PPARγ Dual-Target Agonists through an Innovative Scheme for Regioselective Modification of Silybin. | ACS Omega | 2022 | 35128289 | PubTator, text mining | PubMed |
| H6PD overexpression promotes ex vivo expansion of human cord blood hematopoietic stem cells. | Stem Cell Rev Rep | 2022 | 35122629 | PubTator, text mining | PubMed |
| Fourth-generation glucose sensors composed of copper nanostructures for diabetes management: A critical review. | Bioeng Transl Med | 2022 | 35111949 | PubTator, text mining | PubMed |
| Continuous glucose monitoring devices: A brief presentation (Review). | Exp Ther Med | 2022 | 35069855 | PubTator, text mining | PubMed |
| Enhancement of the Detection Performance of Paper-Based Analytical Devices by Nanomaterials. | Molecules | 2022 | 35056823 | PubTator, text mining | PubMed |
| The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression. | Int J Mol Sci | 2022 | 35054987 | PubTator, text mining | PubMed |
| Lipid profile, lipid ratios, apolipoproteins, and risk of cardiometabolic multimorbidity in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. | Lipids | 2022 | 35049039 | PubTator, text mining | PubMed |
| Intracranial hypertension and empty Sella from adrenal adenoma and excessive and prolonged steroid usage: a case report. | BMC Endocr Disord | 2022 | 35033053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9563/papers?page=34